As shown in Table 1, 31 X-linked mouse genes have shown some evidence for escape from XCI (defined as either greater than 10% expression from the Xi or bi-allelic expression) in brain, neural stem cell and/or kidney cell lines.
Here we define the roles of stem cells in kidney development, discuss how the adult kidney responds to damage, and explore the current knowledge about the existence of adult renal stem cells.
The present review explores the current understanding of renal stem cells and kidney regeneration events, and examines the future challenges in using these insights to create new clinical treatments for kidney disease.
However, the homeostasis of renal stem cells in kidney is still under investigation.
Identification of stem cells in kidney tissues is important for therapeutic applications and for understanding developmental processes and tissue homeostasis.
Gene expression events were extracted using machine learning algorithms trained on manually annotated corpora from two domains, human embryonic stem cells and kidney cell research.
Hence, the hESC obtained from the embryo could be used as savior cells for tissue regeneration in several models of human disease, e.g. hematopoietic stem cells (HSC), kidney cells and pancreatic beta-cells.
In this review, the role of renotropic factors and intra- or extrarenal stem cells in kidney regeneration after injury is summarized.
Following hematological reconstitution and ischemia-reperfusion (I/R), Sca-1 and c-Kit positive renal stem cells in kidney were evaluated by immunostaining and flow cytometry analysis.
Although the results suggest potential utility of stem cells in kidney bioengineering, further work is required to develop protocols for the differentiation of stem cells into mature human renal proximal tubule cells and other renal cell types in vitro.
As expected, SALL4 promoter activity was higher in stem cell and embryonic kidney cell lines but lower in fibroblasts, as reflected by luciferase assays.
